|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's 18th Annual Industry Auditabout 6 years ago
Product Development: The Optimizer’s Curseover 6 years ago
Setting Your Launch Pathover 6 years ago
Pre-launch Prep: The Modern Protocolover 6 years ago
The Murky Outlook for Generic Drugsover 6 years ago
Post-Launch Birthday: The Time to Refineover 6 years ago
Product Launch: Five Paths Forwardover 6 years ago
Once Upon a Brandover 6 years ago
Country Report: Chinaover 6 years ago
Other Products to WatchNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
